These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 15791509)

  • 41. Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: a two-center study.
    Dang NC; Topkara VK; Leacche M; John R; Byrne JG; Naka Y
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):693-8. PubMed ID: 16153915
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of recurrent heart failure associated with left ventricular assist device dysfunction.
    Jaski BE; Miller DA; Hoagland PM; Gordon JB; Chillcott SR; Stahovich MJ; Adamson RM; Baradarian S; Dembitsky WP
    J Heart Lung Transplant; 2005 Dec; 24(12):2060-7. PubMed ID: 16364850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices.
    Zimpfer D; Zrunek P; Sandner S; Schima H; Grimm M; Zuckermann A; Wolner E; Wieselthaler G
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):698-702. PubMed ID: 17289396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renal function and outcome after continuous flow left ventricular assist device implantation.
    Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Grimm M; Wolner E; Wieselthaler GM
    Ann Thorac Surg; 2009 Apr; 87(4):1072-8. PubMed ID: 19324130
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Duration of left ventricular assist device support affects transplant survival.
    Ashton RC; Goldstein DJ; Rose EA; Weinberg AD; Levin HR; Oz MC
    J Heart Lung Transplant; 1996 Nov; 15(11):1151-7. PubMed ID: 8956124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation.
    Monkowski DH; Axelrod P; Fekete T; Hollander T; Furukawa S; Samuel R
    Transpl Infect Dis; 2007 Jun; 9(2):114-20. PubMed ID: 17461996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multidrug-resistant gram-positive infections in patients with ventricular assist devices: the role of daptomycin.
    Beiras-Fernandez A; Kur F; Kiefer S; Sodian R; Schmoeckel M; Weis M; Reichart B; Weis F
    Transplant Proc; 2009; 41(6):2589-91. PubMed ID: 19715980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of continuous milrinone therapy as bridge to transplant is safe in patients with short waiting times.
    Assad-Kottner C; Chen D; Jahanyar J; Cordova F; Summers N; Loebe M; Merla R; Youker K; Torre-Amione G
    J Card Fail; 2008 Dec; 14(10):839-43. PubMed ID: 19041047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ventricular assist device support in children and adolescents as a bridge to heart transplantation.
    Sharma MS; Webber SA; Morell VO; Gandhi SK; Wearden PD; Buchanan JR; Kormos RL
    Ann Thorac Surg; 2006 Sep; 82(3):926-32. PubMed ID: 16928510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients.
    Feller ED; Sorensen EN; Haddad M; Pierson RN; Johnson FL; Brown JM; Griffith BP
    Ann Thorac Surg; 2007 Mar; 83(3):1082-8. PubMed ID: 17307463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of diabetes on short- and long-term outcomes after left ventricular assist device implantation.
    Topkara VK; Dang NC; Martens TP; Cheema FH; Liu JF; Liang LM; Cheema AF; Barili F; Oz MC; Naka Y
    J Heart Lung Transplant; 2005 Dec; 24(12):2048-53. PubMed ID: 16364848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Importance of early appropriate intervention including antibiotics and wound care for device-related infection in patients with left ventricular assist device.
    Hieda M; Sata M; Seguchi O; Yanase M; Murata Y; Sato T; Sunami H; Nakajima S; Watanabe T; Hori Y; Wada K; Hata H; Fujita T; Kobayashi J; Nakatani T
    Transplant Proc; 2014 Apr; 46(3):907-10. PubMed ID: 24767378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial.
    Dembitsky WP; Tector AJ; Park S; Moskowitz AJ; Gelijns AC; Ronan NS; Piccione W; Holman WL; Furukawa S; Weinberg AD; Heatley G; Poirier VL; Damme L; Long JW
    Ann Thorac Surg; 2004 Dec; 78(6):2123-9; discussion 2129-30. PubMed ID: 15561049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe.
    Pae WE; Connell JM; Adelowo A; Boehmer JP; Korfer R; El-Banayosy A; Hetzer R; Vigano M; Pavie A;
    J Heart Lung Transplant; 2007 Mar; 26(3):219-29. PubMed ID: 17346623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does the type of ventricular assisted device influence survival, infection, and rejection rates following heart transplantation?
    Shuhaiber J; Hur K; Gibbons R
    J Card Surg; 2009; 24(3):250-5. PubMed ID: 19438776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Implantable left ventricular assist devices: new hope for patients with end-stage heart failure.
    Milano CA; Lodge AJ; Blue LJ; Smith PK; Felker GM; Hernandez AF; Rosenberg PB; Rogers JG
    N C Med J; 2006; 67(2):110-5. PubMed ID: 16752713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First clinical experience with the Incor left ventricular assist device.
    Schmid C; Tjan TD; Etz C; Schmidt C; Wenzelburger F; Wilhelm M; Rothenburger M; Drees G; Scheld HH
    J Heart Lung Transplant; 2005 Sep; 24(9):1188-94. PubMed ID: 16143232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Papworth experience with the Levitronix CentriMag ventricular assist device.
    Shuhaiber JH; Jenkins D; Berman M; Parameshwar J; Dhital K; Tsui S; Large SR
    J Heart Lung Transplant; 2008 Feb; 27(2):158-64. PubMed ID: 18267221
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates.
    Salzberg SP; Lachat ML; von Harbou K; Zünd G; Turina MI
    Eur J Cardiothorac Surg; 2005 Feb; 27(2):222-5. PubMed ID: 15691674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.